Acrivon Therapeutics Inc
(ACRV)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2021 | 09-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||
| Net Income | -16,243 | -11,900 | -5,306 |
| Depreciation Amortization | 37 | 24 | 13 |
| Accounts payable and accrued liabilities | N/A | 494 | N/A |
| Other Working Capital | 328 | 187 | 317 |
| Other Operating Activity | 1,896 | 840 | 2,173 |
| Operating Cash Flow | $-13,982 | $-10,355 | $-2,803 |
| Cash Flows From Investing Activities | |||
| PPE Investments | -238 | -101 | -15 |
| Investing Cash Flow | $-238 | $-101 | $-15 |
| Cash Flows From Financing Activities | |||
| Common Stock Issued | N/A | 1 | N/A |
| Other Financing Activity | 112,221 | 12,467 | 2,889 |
| Financing Cash Flow | $112,221 | $12,468 | $2,889 |
| Beginning Cash Position | 1,990 | 1,990 | 1,919 |
| End Cash Position | 99,991 | 4,002 | 1,990 |
| Net Cash Flow | $98,001 | $2,012 | $71 |
| Free Cash Flow | |||
| Operating Cash Flow | -13,982 | -10,355 | -2,803 |
| Capital Expenditure | N/A | -101 | N/A |
| Free Cash Flow | -13,982 | -10,456 | -2,803 |